Go Pro
→ A major gold reset could be closer than people think (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANGLE plc stock logo
ANPCY
ANGLE
C$0.07
C$0.07
C$0.07
▼
C$2.39
N/AN/A11,295 shsN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
$0.09
-3.0%		$0.11
$0.08
▼
$0.60
N/AN/A12,043 shs5,801 shs
BG Medicine Inc. stock logo
BGMD
BG Medicine
$0.00
$0.00
▼
$0.00
N/A1.02N/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
$1.35
+2.3%		$1.39
$1.15
▼
$20.25
N/AN/A20,327 shs161,767 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANGLE plc stock logo
ANPCY
ANGLE
0.00%0.00%0.00%0.00%-85.62%
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
-7.81%-19.07%-29.52%-32.77%-77.65%
BG Medicine Inc. stock logo
BGMD
BG Medicine
0.00%0.00%0.00%0.00%0.00%
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
0.00%+1.50%-2.17%-13.46%-43.04%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANGLE plc stock logo
ANPCY
ANGLE
C$0.07
C$0.07
C$0.07
▼
C$2.39
N/AN/A11,295 shsN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
$0.09
-3.0%		$0.11
$0.08
▼
$0.60
N/AN/A12,043 shs5,801 shs
BG Medicine Inc. stock logo
BGMD
BG Medicine
$0.00
$0.00
▼
$0.00
N/A1.02N/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
$1.35
+2.3%		$1.39
$1.15
▼
$20.25
N/AN/A20,327 shs161,767 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANGLE plc stock logo
ANPCY
ANGLE
0.00%0.00%0.00%0.00%-85.62%
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
-7.81%-19.07%-29.52%-32.77%-77.65%
BG Medicine Inc. stock logo
BGMD
BG Medicine
0.00%0.00%0.00%0.00%0.00%
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
0.00%+1.50%-2.17%-13.46%-43.04%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ANGLE plc stock logo
ANPCY
ANGLE
0.00
N/AN/AN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
0.00
N/AN/AN/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
0.00
N/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/AN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
$298.80KN/AN/AN/AN/AN/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
N/AN/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ANGLE plc stock logo
ANPCY
ANGLE
N/A-C$0.48N/AN/AN/AN/AN/AN/AN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
N/AN/AN/AN/AN/AN/AN/AN/AN/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
N/AN/AN/AN/AN/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
N/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ANGLE plc stock logo
ANPCY
ANGLE
N/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
N/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
N/A
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
N/A

Insider Ownership

CompanyInsider Ownership
ANGLE plc stock logo
ANPCY
ANGLE
N/A
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
N/A
BG Medicine Inc. stock logo
BGMD
BG Medicine
6.50%
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ANGLE plc stock logo
ANPCY
ANGLE
173N/AN/ANot Optionable
Bullfrog AI Holdings, Inc. stock logo
BFRGW
Bullfrog AI
2N/AN/ANot Optionable
BG Medicine Inc. stock logo
BGMD
BG Medicine
5N/AN/ANot Optionable
ImmunoPrecise Antibodies Ltd. stock logo
IPATF
ImmunoPrecise Antibodies
80N/AN/ANot Optionable

Recent News About These Companies

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) Q3 2026 earnings call transcript
March 15, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/immunoprecise-antibodies-ltd-nasdaq-ipa-q3-2026-earnings-call-transcript/ar-AA1YFiiw
ImmunoPrecise evolves into MindWalk to reflect AI-focused future
September 4, 2025  |  fiercepharma.comF
ImmunoPrecise rebrands as MindWalk, reflects shift to AI platform
September 3, 2025  |  msn.comhttps://www.msn.com/en-us/news/technology/immunoprecise-rebrands-as-mindwalk-reflects-shift-to-ai-platform/ar-AA1LOee7
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to "HYFT"
September 3, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/09/03/10247852.htm
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript
July 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/immunoprecise-antibodies-ltd-nasdaqipa-q4-2025-earnings-call-transcript/ar-AA1JA16z
A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast
March 27, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/03/44515321/a-look-ahead-immunoprecise-antibodiess-earnings-forecast
ImmunoPrecise Antibodies: Q2 Earnings Insights
December 10, 2024  |  benzinga.comhttps://www.benzinga.com/insights/earnings/24/12/42412532/immunoprecise-antibodies-q2-earnings-insights
ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology
October 23, 2024  |  msn.comhttps://www.msn.com/en-us/health/other/immunoprecise-touts-potential-of-rabbit-monoclonal-antibodies-in-oncology/ar-AA1sFN4j
ImmunoPrecise Antibodies (NASDAQ:IPA) Stock, Earnings Estimates, EPS, And Revenue
October 6, 2024  |  benzinga.comhttps://www.benzinga.com/quote/IPA/earnings
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer
October 3, 2024  |  msn.comhttps://www.msn.com/en-us/health/other/immunoprecise-and-biotheus-partner-on-bispecific-antibodies-to-treat-cancer/ar-AA1rEL7Q
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2024 Earnings Call Transcript
July 30, 2024  |  msn.comhttps://www.msn.com/en-us/money/companies/immunoprecise-antibodies-ltd-nasdaqipa-q4-2024-earnings-call-transcript/ar-BB1qT1YY
Immunoprecise Antibodies Ltd (IPA)
May 16, 2024  |  investing.comhttps://www.investing.com/equities/tanqueray-exploration-ltd-commentary
EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications
March 28, 2024  |  benzinga.comhttps://www.benzinga.com/general/biotech/24/03/37977700/exclusive-immunoprecise-antibodies-and-intersystems-integrate-vector-search-with-lensai-for-ai-dr
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
February 12, 2024  |  benzinga.comhttps://www.benzinga.com/general/biotech/24/02/37066350/immunoprecise-antibodies-nasdaq-ipa-is-changing-how-we-look-at-the-complex-world-of-antibody-disc
Immunoprecise Antibodies announces collaboration with Xyphos on antibodies against TME target
April 2, 2023  |  bioworld.comB
ImmunoPrecise Antibodies' Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio
March 17, 2023  |  stockhouse.comhttps://stockhouse.com/news/press-releases/2023/03/15/immunoprecise-antibodies-subsidiary-talem-therapeutics-announces-a-multi-target
Transporting antibodies across the blood–brain barrier to treat Alzheimer's disease
March 11, 2023  |  phys.orgP
Sugar-coated antibodies cross blood-brain barrier to fight Alzheimer's
March 11, 2023  |  newatlas.comN
An antibody injection could one day help people with endometriosis
March 11, 2023  |  sciencenews.orgS
Check this out: Researchers design new approach to creating antibody libraries
March 8, 2023  |  hub.jhu.eduH

Media Sentiment Over Time

ANGLE stock logo

ANGLE OTCMKTS:ANPCY

C$0.07 0.00 (0.00%)
As of 09/10/2026

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRGW

$0.09 0.00 (-3.00%)
As of 09/11/2026 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

BG Medicine stock logo

BG Medicine OTCMKTS:BGMD

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

ImmunoPrecise Antibodies stock logo

ImmunoPrecise Antibodies OTCMKTS:IPATF

$1.35 +0.03 (+2.27%)
As of 09/8/2026

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas